Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

被引：9

作者：

Lesieur, Auriane ^{[1
]}

Thomas, Xavier ^{[2
]}

Nibourel, Olivier ^{[1
,3
]}

Boissel, Nicolas ^{[4
]}

Fenwarth, Laurene ^{[1
,3
]}

De Botton, Stephane ^{[5
]}

Fournier, Elise ^{[1
,3
]}

Celli-Lebras, Karine ^{[4
]}

Raffoux, Emmanuel ^{[4
]}

Recher, Christian ^{[6
]}

Lambert, Juliette ^{[7
]}

Berthon, Celine ^{[3
,8
]}

Pigneux, Arnaud ^{[9
]}

Itzykson, Raphael ^{[4
]}

Turlure, Pascal ^{[10
]}

Pautas, Cecile ^{[11
]}

Vargaftig, Jacques ^{[12
]}

Preudhomme, Claude ^{[1
,3
]}

Dombret, Herve ^{[4
]}

Duployez, Nicolas ^{[1
,3
]}

机构：

[1] CHU Lille, Lab Hematol, Lille, France

[2] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Lyon, France

[3] Univ Lille, Canther Canc Heterogene Plast & Resistance Therap, Inst Rech Canc Lille, CHU Lille,Inserm,CNRS,UMR9020,UMR S 1277, Lille, France

[4] Univ Paris, St Louis Res Inst, St Louis Hosp, Dept Hematol,AP HP, Paris, France

[5] Gustave Roussy Inst, Dept Hematol, Villejuif, France

[6] Toulouse Canc Univ Inst, Dept Hematol, Toulouse, France

[7] CH Versailles, Dept Hematol, Le Chesnay, France

[8] CHU Lille, Dept Clin Hematol, Lille, France

[9] Bordeaux Haut Leveque Univ Hosp, Dept Hematol, Pessac, France

[10] Univ Limoges, CHU Limoges, Dept Hematol, Limoges, France

[11] Henri Mondor Hosp, AP HP, Dept Hematol, Creteil, France

[12] Rene Huguenin Hosp, Curie Hosp, St Cloud, France

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 06期

关键词：

NUCLEOPHOSMIN; AML;

D O I：

10.3324/haematol.2020.260133

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1767 / 1769

页数：3

共 50 条

[1] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
W-C Chou
J-L Tang
S-J Wu
W Tsay
M Yao
S-Y Huang
K-C Huang
C-Y Chen
C-F Huang
H-F Tien
Leukemia, 2007, 21 : 998 - 1004
[2] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
Chou, W-C
Tang, J-L
Wu, S-J
Tsay, W.
Yao, M.
Huang, S-Y
Huang, K-C
Chen, C-Y
Huang, C-F
Tien, H-F
LEUKEMIA, 2007, 21 (05) : 998 - 1004
[3] Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Mencia-Trinchant, Nuria
Hu, Yang
Alas, Maria Antonina
Ali, Fatima
Wouters, Bas J.
Lee, Sangmin
Ritchie, Ellen K.
Desai, Pinkal
Guzman, Monica L.
Roboz, Gail J.
Hassane, Duane C.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (04): : 537 - 548
[4] NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring
Wang, Peng
Segal, Jeremy
Drazer, Michael W.
Venkataraman, Girish
Arber, Daniel A.
Gurbuxani, Sandeep
EJHAEM, 2022, 3 (03): : 962 - 965
[5] Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient-specific NPM1 mutations
Dvorakova, Dana
Racil, Zdenek
Jeziskova, Ivana
Palasek, Ivo
Protivankova, Marketa
Lengerova, Martina
Razga, Filip
Mayer, Jiri
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (12) : 926 - 929
[6] Clinical Deep Sequencing of NPM1 for Minimal Residual Disease Detection in Acute Myeloid Leukemia
Hoyle, Eric
Murillo, Lena
Nesbitt, Shannon
Zhou, Yi
Wood, Brent L.
Salipante, Stephen J.
Wu, David
LABORATORY INVESTIGATION, 2016, 96 : 353A - 353A
[7] Clinical Relevance of Minimal Residual Disease Monitroing in Npm1 Mutated Acute Myeloid Leukemia
Doehner, K.
ANNALS OF HEMATOLOGY, 2013, 92 : S39 - S39
[8] EVALUATION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH NPM1 MARKER
Alizadghandforoush, N.
Nadali, F.
Rostami, S.
Chahardouli, B.
Ghadimi, H.
Ghasemi, A.
Alimoghaddam, K.
Ghavamzadeh, A.
HAEMATOLOGICA, 2015, 100 : 657 - 658
[9] Clinical Deep Sequencing of NPM1 for Minimal Residual Disease Detection in Acute Myeloid Leukemia
Hoyle, Eric
Murillo, Lena
Nesbitt, Shannon
Zhou, Yi
Wood, Brent L.
Salipante, Stephen J.
Wu, David
MODERN PATHOLOGY, 2016, 29 : 353A - 353A
[10] Assessment of Minimal Residual Disease by NGS in Acute Myeloid Leukemia Patients by Monitoring FLT3 and NPM1 Mutations
Xie, Z.
Carson, A. R.
McClain, V.
Miller, J. E.
Levis, M.
Stenzel, T.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S10 - S10

← 1 2 3 4 5 →